Awards, Accreditations & Quality Compliance

In 2026 SSR was recognized for outstanding contributions to life sciences, operational excellence, and high-quality clinical trial delivery across Australia and the Asia-Pacific region at the Asia-Pacific Bioprocessing Excellence Awards 2026, presented by IMAPAC.

Recognizing an outstanding contribution to advancing Australian clinical research internationally, Southern Star Research (SSR) was honored as the 2025 NSW Exporter of the Year. This prestigious accolade celebrates our success in delivering high-quality, full-service clinical trial solutions to global biotech and pharmaceutical partners.

In a highly competitive field, SSR won the 2025 International Health Award. This recognition highlights our success in expanding Australian clinical research globally and providing world-class infrastructure to international sponsors.

Received in recognition of the company’s excellence, innovation, and significant contributions to the medical and scientific fields throughout the Asia-Pacific region. Awarded by MedHealth Outlook.

Certified by Compass Assurance Services, this accreditation is the global benchmark for quality management. SSR has achieved zero findings for two consecutive years, ensuring our operational framework is audit-ready and compliant with international regulatory standards.

This certification, achieved across two consecutive years to date, highlights our commitment to fostering a high-performing, supportive, and engaged team culture. We believe that an empowered team directly impacts project success, data integrity, and client satisfaction.

Awarded by one of the world’s premier growth strategy firms, this honor recognizes SSR’s leadership and strategic excellence in the APAC clinical research market.